Advanced Diabetes Diagnostic Tests Now Available in Europe
|
By LabMedica International staff writers Posted on 28 Sep 2014 |
|
Image: The Quantose IR test is a laboratory-developed test (LDT) that measures the concentration of four metabolites: alpha-hydroxybutyrate (AHB), linoleoyglycerophosphocholine (L-GPC), oleic acid, and insulin (Photo courtesy of Metabolon, Inc.).
A pair of advanced diagnostic tests that help identify individual with type II diabetes or pre-diabetic conditions are now available for use by hospital and clinical laboratories in Europe.
Metabolon, Inc., (Research Triangle Park, NC, USA) a global leader in the field of diagnostic metabolomics, will be marketing its Quantose IR and Quantose IGT pre-diabetes tests in Europe via the Spanish biomedical company Metdia Biotech, S.L.
Quantose IR is an LDT (laboratory-developed test) that indicates levels of insulin resistance. This blood test is based on insulin and three nonglycemic biomarkers (alpha-hydroxybutyrate, linoleoyglycerophosphocholine, and oleic acid). It assesses risk of progression to pre-diabetes earlier than traditional glycemic markers such a hemoglobin A1c. The Quantose IGT assay is an LDT that measures the degree of impaired glucose tolerance. Impaired glucose tolerance is a core metabolic defect in dysglycemia and is a known risk factor for pre-diabetes. Quantose IGT may be used as an alternative to the oral glucose tolerance test (OGTT).
"Diabetes is a significant global health concern, and the costs to society are high and growing rapidly," said Oscar Rodriguez, director of Metdia Biotech. "According to the International Diabetes Federation, more than 55 million adults in the European Region are coping with diabetes every day. Another 66 million have impaired glucose tolerance, a known risk factor for pre-diabetes. Tests using Metabolon's Quantose technology provide cost-effective assessment tools that help physicians identify patients with pre-diabetes and monitor the impact of therapeutic interventions. If pre-diabetes is caught early, physicians can prescribe treatment that might prevent progression to type II diabetes."
"Licensing our Quantose IR and Quantose IGT technology to Metdia in Europe is an important next step in expanding the availability of these obesity-related diagnostic tests outside the US," said Dr. John Ryals, president and CEO at Metabolon. "We are confident in Metdia's broad knowledge of the molecular diagnostics market in Europe."
Metdia will market the tests to hospitals and clinical laboratories in Spain, Portugal, France, Italy, the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, Finland, the Netherlands, Belgium, and Austria.
Related Links:
Metabolon, Inc.
Metabolon, Inc., (Research Triangle Park, NC, USA) a global leader in the field of diagnostic metabolomics, will be marketing its Quantose IR and Quantose IGT pre-diabetes tests in Europe via the Spanish biomedical company Metdia Biotech, S.L.
Quantose IR is an LDT (laboratory-developed test) that indicates levels of insulin resistance. This blood test is based on insulin and three nonglycemic biomarkers (alpha-hydroxybutyrate, linoleoyglycerophosphocholine, and oleic acid). It assesses risk of progression to pre-diabetes earlier than traditional glycemic markers such a hemoglobin A1c. The Quantose IGT assay is an LDT that measures the degree of impaired glucose tolerance. Impaired glucose tolerance is a core metabolic defect in dysglycemia and is a known risk factor for pre-diabetes. Quantose IGT may be used as an alternative to the oral glucose tolerance test (OGTT).
"Diabetes is a significant global health concern, and the costs to society are high and growing rapidly," said Oscar Rodriguez, director of Metdia Biotech. "According to the International Diabetes Federation, more than 55 million adults in the European Region are coping with diabetes every day. Another 66 million have impaired glucose tolerance, a known risk factor for pre-diabetes. Tests using Metabolon's Quantose technology provide cost-effective assessment tools that help physicians identify patients with pre-diabetes and monitor the impact of therapeutic interventions. If pre-diabetes is caught early, physicians can prescribe treatment that might prevent progression to type II diabetes."
"Licensing our Quantose IR and Quantose IGT technology to Metdia in Europe is an important next step in expanding the availability of these obesity-related diagnostic tests outside the US," said Dr. John Ryals, president and CEO at Metabolon. "We are confident in Metdia's broad knowledge of the molecular diagnostics market in Europe."
Metdia will market the tests to hospitals and clinical laboratories in Spain, Portugal, France, Italy, the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, Finland, the Netherlands, Belgium, and Austria.
Related Links:
Metabolon, Inc.
Gold Member
Troponin T QC
Troponin T Quality Control
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
Latest Clinical Chem. News
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
Channels
Molecular Diagnostics
view channel
Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more
Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
Cardiovascular diseases (CVD) continue to be the leading cause of death globally, responsible for nearly one-third of all fatalities worldwide. Traditionally, risk assessment for CVD has focused on well-established... Read more
Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
Neonatal sepsis, which occurs due to the body’s abnormal response to severe infection within the first 28 days of life, results in approximately 200,000 deaths globally each year. This condition affects around 1.... Read more.jpeg "Image: Researchers integrated multiple protein markers to predict health outcomes in individuals with chronic kidney disease (Photo courtesy of Adobe Stock)")
Integrating Multiple Protein Markers Predicts Health Outcomes in Chronic Kidney Disease Patients
Previous attempts to discover novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have generally focused on evaluating proteins individually, which limits their prognostic... Read moreHematology
view channel
Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more
Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more
Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more
Immunology
view channel
Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients
Immunotherapy aims to enhance the body’s immune response to target cancer cells, but not all patients experience a positive reaction to such treatments. Identifying which patients will benefit from immunotherapy... Read more
Biomarker Could Predict Immunotherapy Response in Liver Cancer
Until recently, patients diagnosed with hepatocellular carcinoma had limited treatment options, with existing therapies extending life by only a few months. Immunotherapy has emerged as a new alternative... Read more
Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma
Multiple myeloma is a blood cancer that primarily affects individuals over the age of sixty, and its occurrence rises as the population ages. In this disease, the bone marrow—the spongy tissue inside bones... Read more
Microbiology
view channel
High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more_1.jpg "Image: Researchers have developed a method to quickly identify the most appropriate treatments for bacterial infections (Photo courtesy of Shutterstock)")
Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
For patients with bacterial infections, timely treatment with the appropriate antibiotics significantly improves their chances of recovery. Current methods for identifying which antibiotics will be effective... Read more
Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the... Read more
Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR
Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read morePathology
view channel
New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers
Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more
Faster Measurement of Vibrational Fingerprint of Molecules to Advance Biomedical Diagnostics
Identifying different types of molecules and cells is a vital process in both basic and applied science. Raman spectroscopy serves as a widely utilized measurement technique for this purpose.... Read more
Technology
view channel
New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC
Exposure to lead can negatively affect health in multiple ways, leading to damage in the brain and central nervous system, delays in development and growth, learning and behavioral issues, problems with... Read more
Noninvasive Test Detects Malaria Without Blood Sample
Malaria remains a significant global health issue, with approximately 250 million cases and over 600,000 deaths reported annually. Nearly half of the world's population is at risk for malaria infection,... Read more
Industry
view channel
Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests
Acute kidney injury (AKI) is a sudden episode of kidney failure or damage that can occur within a few hours or days. This condition leads to the accumulation of waste products in the blood and disrupts... Read more_1.jpg "Image: CACLP 2025 will return on 21-24 March 2025 to attract professionals across the IVD industry (Photo courtesy of CACLP)")
CACLP 2025 New Date and Venue Announced
The 22nd China International In Vitro Diagnostic Expo, organized by the China Association of Clinical Laboratory Practice Expo (CACLP, Shanghai, China), is set to take place from March 21 to 24, 2025,... Read more
Roche to Develop New Diagnostic Technologies for Traumatic Brain Injuries
Traumatic brain injuries (TBI) represent a significant global health issue, affecting approximately 69 million people each year. TBI occurs when an external force disrupts normal brain function, with severity... Read more